Article info

Download PDFPDF

Original research article
Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trial

Authors

  1. Correspondence to Professor Thomas Engstrøm, Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen 2100, Denmark ; thomas.engstroem{at}regionh.dk
View Full Text

Citation

Engstrøm T, Nepper-Christensen L, Helqvist S, et al
Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trial

Publication history

  • Received November 27, 2017
  • Revised February 28, 2018
  • Accepted February 28, 2018
  • First published March 30, 2018.
Online issue publication 
September 13, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.